Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.
about
Insights into gastric neuroendocrine tumors burdenPharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents.Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist.Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
P2860
Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effect of netazepide, a gastri ...... trinaemia in healthy subjects.
@ast
Effect of netazepide, a gastri ...... trinaemia in healthy subjects.
@en
type
label
Effect of netazepide, a gastri ...... trinaemia in healthy subjects.
@ast
Effect of netazepide, a gastri ...... trinaemia in healthy subjects.
@en
prefLabel
Effect of netazepide, a gastri ...... trinaemia in healthy subjects.
@ast
Effect of netazepide, a gastri ...... trinaemia in healthy subjects.
@en
P2093
P2860
P356
P1476
Effect of netazepide, a gastri ...... strinaemia in healthy subjects
@en
P2093
Chun-Mei Zhao
Frans van den Berg
Gillian Turnbull
James Black
Sally Dowen
P2860
P304
P356
10.1111/BCP.12534
P407
P577
2015-05-01T00:00:00Z